Allan Sylvest Aasberg

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Allan Sylvest Aasberg's trades of EQL Pharma AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
14.75
Quantity 39,253
Value SEK1,803,653
Transaction date
Purchase
Price
132.71
Quantity 29,648
Value SEK4,276,439
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-14
B Purchase
39,253
14.75
SEK1,803,653 		39,253 14.75 SEK1,803,653
2026-08-17 2026-08-14
B Purchase
29,648
132.71
SEK4,276,439 		29,648 132.71 SEK4,276,439